Search

Search Results
Results 7061 - 7070 of 7082 for Anti-aging"
  • Rukobia Tablets
    Drug - 5 Aug 2021
    Consumer Medicine Information (CMI) about Rukobia Tablets intended for persons living in Australia.
  • BiResp Spiromax
    Drug - 27 Jul 2021
    Consumer Medicine Information (CMI) about BiResp Spiromax intended for persons living in Australia.
  • Betmiga
    Drug - 21 Jul 2021
    Consumer Medicine Information (CMI) about Betmiga intended for persons living in Australia.
  • DuoResp Spiromax
    Drug - 6 May 2021
    Consumer Medicine Information (CMI) about DuoResp Spiromax intended for persons living in Australia.
  • DBL Heparin Sodium
    Drug - 30 Mar 2021
    Consumer Medicine Information (CMI) about DBL Heparin Sodium (Heparin Sodium) intended for persons living in Australia.
  • Lecteva
    Drug - 15 Oct 2020
    Consumer Medicine Information (CMI) about Lecteva (levodopa/carbidopa/entacapone) intended for persons living in Australia.
  • Valcyte Tablets
    Drug - 15 Oct 2020
    Consumer Medicine Information (CMI) about Valcyte Tablets (valganciclovir) intended for persons living in Australia.
  • Valcyte Powder for Oral Solution
    Drug - 15 Oct 2020
    Consumer Medicine Information (CMI) about Valcyte Powder for Oral Solution (valganciclovir) intended for persons living in Australia.
  • Zelboraf
    Drug - 7 Apr 2020
    Consumer Medicine Information (CMI) about Zelboraf (vemurafenib) intended for persons living in Australia.
  • Sodium Bicarbonate
    Drug - 7 Apr 2020
    Consumer Medicine Information (CMI) about Sodium Bicarbonate intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback